Biovie Inc.
BIVIW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580149
In the last 90 days, Biovie Inc. insiders filed 4 open-market purchases and 0 sales; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.07M in total; no superinvestor holds it.
Other share classesBIVI
Holders of 5% or more of BIVIW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biovie Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Biovie Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Biovie Inc., newest first.
No Schedule 13D or 13G filings on Biovie Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biovie Inc. shares.
No Form 144 notices for Biovie Inc. are on file.